Rapamycin can inhibit the activity of mechanistic target of rapamycin (mTOR), decrease proliferation of T lymphocytes to reduce adipogenesis and enhance lipogenesis and induce tumor immune evasion [70, 71]. This evidence concerns the gene MTOR and neoplasm.